Piper Sandler analyst David Amsellem upgrades Alkermes (NASDAQ:ALKS) from Neutral to Overweight and raises the price target from $26 to $30.
AECOM Likely To Report Higher Q4 Earnings; Here’s A Look At Recent Price Target Changes By The Most Accurate Analysts
AECOM (NYSE: ACM) is projected to release financial results for its fourth quarter, after the closing bell on Nov. 13, 2023.